Cyanide, vitamin B-12, experimental demyelination and tobacco amblyopia.
D000550:Amblyopia / Q000188:drug therapy*; D000818:Animals; D003486:Cyanides / Q000633:toxicity*; D003711:Demyelinating Diseases; D006801:Humans; D006879:Hydroxocobalamin / Q000494:pharmacology* / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D012907:Smoking; D014805:Vitamin B 12 / Q000494:pharmacology*
D003486:Cyanides; D014805:Vitamin B 12; D006879:Hydroxocobalamin
Lancet. 1961 Apr 29;1(7183):908-11
13701624
Exp Neurol. 1961 Nov;4:402-12
13924587
J Neurol Neurosurg Psychiatry. 1963 Dec;26:479-86
14083218
J Biol Chem. 1956 Jan;218(1):449-57
13278352
Nature. 1963 Oct 12;200:179-81
14073042
Proc Soc Exp Biol Med. 1951 Jul;77(3):416-8
14864609
Exp Neurol. 1961 Nov;4:444-59
13894010
Am J Clin Nutr. 1955 Sep-Oct;3(5):383-90
13258512
J Pharm Pharmacol. 1953 Oct;5(10):723-36
13097363
Brain. 1963 Jun;86:347-62
14001038
Proc Soc Exp Biol Med. 1952 Oct;81(1):234-7
13047367